Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2017, Article ID 3729629, 3 pages
https://doi.org/10.1155/2017/3729629
Case Report

An Intact Dopamine Sensitivity in the Brain: A Necessity to Recover Hyperprolactinemia and Galactorrhea in a Female Hemodialysis Patient?

1Department of Endocrinology, University Hospital of Antwerp, Edegem, Belgium
2Department of Nephrology, University Hospital of Antwerp, Edegem, Belgium

Correspondence should be addressed to Eva Philipse; eb.azu@espilihp.ave

Received 27 February 2017; Accepted 13 June 2017; Published 16 July 2017

Academic Editor: Władysław Sułowicz

Copyright © 2017 Eva Philipse et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Yavuz, G. Topçu, Ç. Özener, S. Akalin, and Ö. Sirikçi, “Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy,” Clinical Endocrinology, vol. 63, no. 5, pp. 520–524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Ramirez, W. M. O'Neill, H. A. Bloomer, and W. Jubiz, “Abnormalities in the regulation of prolactin in patients with chronic renal failure,” The Journal of Clinical Endocrinology & Metabolism, vol. 45, no. 4, pp. 658–661, 1977. View at Publisher · View at Google Scholar
  3. H. Bry-Gauillard, P. Touraine, M.-F. Mamzer-Bruneel, A. Simoes-Vaz, F. Kuttenn, and C. Legendre, “Complete regression of a major hyperprolactinaemia after renal transplantation,” Nephrology Dialysis Transplantation, vol. 14, no. 2, pp. 466–468, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. P. B. Kerr, A. Argiles, J.-L. Flavier, B. Canaud, and C. M. Mion, “Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study,” Kidney International, vol. 41, no. 4, pp. 1035–1040, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Al-Husaynei, I. H. Mahmood, and Z. S. Al-Jubori, “Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea,” Middle East Fertility Society Journal, vol. 13, no. 1, pp. 33–38, 2008. View at Google Scholar · View at Scopus
  6. G. D. Sievertsen, V. S. Lim, C. Nakawatase, and L. A. Frohman, “Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure,” Journal of Clinical Endocrinology and Metabolism, vol. 50, no. 5, pp. 846–852, 1980. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kim and Y.-M. Park, “Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: A cross-sectional pilot study,” PLoS ONE, vol. 8, no. 12, Article ID e82749, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. La Torre and A. Falomi, “Pharmacological causes of hyperprolactinemia,” Therapeutics and Clinical Risk Management, vol. 3, no. 5, pp. 929–951, 2007. View at Google Scholar